• In April 2026, Knowles Corporation reported first-quarter 2026 results showing sales rising to US$153.1 million from US$132.2 million a year earlier, with net income improving to US$9.7 million from a loss and diluted earnings per share from continuing operations reaching US$0.13.
• On the same day, the company issued second-quarter 2026 guidance calling for US$152 million to US$162 million in revenue and US$0.18 to US$0.22 in diluted earnings per share from continuing operations, highlighting how stock-based compensation and intangibles amortization are expected to affect reported profitability.
• We’ll now explore how Knowles’ shift to profitability and its guided earnings range for the upcoming quarter may influence its investment narrative.

AI is about to change healthcare. These 33 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

Knowles Investment Narrative Recap

To own Knowles, you need to believe its core medtech, specialty audio, and industrial businesses can support steady revenue while margins hold up against product mix and factory cost pressures. The Q1 2026 move back into positive net income and the Q2 guidance help the near term earnings story, but they do not remove the risk that ongoing ramp inefficiencies and mix shifts could still weigh on profitability if they persist.

The Q2 2026 outlook is the most relevant update here, because it spells out how stock based compensation and intangibles amortization will affect reported earnings, giving a clearer view of underlying profitability. That guidance also sits against a backdrop of modest expected revenue growth and exposure to mature markets, which keeps the focus on whether new products like inductors and specialty films can contribute enough to offset margin and growth headwinds.

Yet behind the improving earnings, there is still meaningful margin pressure risk that investors should be aware of if...

Knowles' narrative projects $716.9 million revenue and $122.3 million earnings by 2029. This requires 6.5% yearly revenue growth and about a $71.4 million earnings increase from $50.9 million today.

Uncover how Knowles' forecasts yield a $28.50 fair value, a 10% downside to its current price.

Exploring Other Perspectives

Some of the lowest ranked analysts were assuming Knowles might reach about US$658 million in revenue and US$159 million in earnings by 2028, yet still apply a much lower valuation, so if you are weighing Q1’s profitable quarter and Q2 guidance against those more cautious forecasts, it is worth remembering that views on future risks like customer concentration can differ sharply and may shift again after this latest update.

Explore 2 other fair value estimates on Knowles - why the stock might be worth as much as 23% more than the current price!

The Verdict Is Yours

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

• A great starting point for your Knowles research is our analysis highlighting 2 key rewards and 1 important warning sign that could impact your investment decision.
• Our free Knowles research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Knowles' overall financial health at a glance.

Seeking Other Investments?

Our daily scans reveal stocks with breakout potential. Don't miss this chance:

• Capitalize on the AI infrastructure supercycle with our selection of the 37 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.
• Find 50 companies with promising cash flow potential yet trading below their fair value.
• Uncover the next big thing with 24 elite penny stocks that balance risk and reward.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.